Compositions and methods for stimulating bone growth
Patent 6022887 Issued on February 8, 2000. Estimated Expiration Date: December 12, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Compounds of the formula ##STR1## wherein X in each of formulas (1) and (2) represents a substituted or unsubstituted alkylene, alkenylene, or alkynylene linker of 2-6C;Y represents one or more carbocyclic or heterocyclic rings; when two or more rings are present in Y, they may optionally be fused; andR' represents a cation, H or a substituted or unsubstituted alkyl group of 1-6C; andthe dotted lines represent optional π-bonds,promote bone formation and are thus usefull in treating osteoporosis, bone fracture or deficiency, primary or secondary hyperparathyroidism, periodontal disease or defect, metastatic bone disease, osteolytic bone disease, post-plastic surgery, post-prosthetic joint surgery, and post-dental implantation.
Other References
Mundy, G.R., "Regulation of Bone Formation by Bone Morphogenetic Proteins and Other Growth Factors," Clinical Orthopaedics and Related Research 323:24-28 (Mar. 1996)
Mundy, G.R., "Cytokines and Growth Factors in the Regulation of Bone Remodeling," Journal of Bone and Mineral Research 8(S2):S505-S510 (Dec. 1993)
Wozney, J.M., et al., "Novel Regulators of Bone Formation: Molecular Clones and Activities," Science (Dec. 16, 1988) 242:1528-1534
Wozney, J.M., "The Bone Morphogenetic Protein Family and Osteogenesis," Molecular Reproduction and Development 32:160-167 (Jun. 1992)
Harris, S.E., et al., "Effects of Transforming Growth Factor ଲon Bone Nodule Formation and Expression of Bone Morphogenetic Protein 2, Osteocalcin, Osteopontin, Alkaline Phosphatase, and Type I Collagen mRNA in Long-Term Cultures of Fetal Rat Calvarial Osteblasts," Journal of Bone Mineral Research 9(6):855-863 (Jun. 1994)
Stein, G.S., et al., "Bone cell differentiation: a functionally coupled relationship between expression of cell-growth-and tissue-specific genes," Current Opinion in Cell Biology 2:1018-1027 (Dec. 1990)
Wang, G-J., et al., "Lipid Clearing Agents in Steroid-induced Osteoporosis," J Formos Med Assoc 94(10):589-592 (Oct. 1995)
Cui, Q., et al., "Lovastatin Prevents Steroid-Induced Adipogenesis and Osteoporosis," Reports of the ASBMR 18th Annual Meeting (Sep. 1996) Journal of Bone and Mineral Research (Aug. 1996) 11 (Supplement 1):S510, p. S217
Bellows, C.G., et al., "Determination of the Capacity for Proliferation and Differentiation of Osteoprogenitor Cells in the Presence and Absence of Dexamethasone,"Developmental Biology 140:132-138 (Jul. 1990)
Rickard, D.J., et al., "Induction of Rapid Osteoblast Differentiation in Rat Bone Marrow Stromal Cell Cultures by Dexamethasone and BMP-2," Developmental Biology 161:218-228 (Jan. 1994)
Ducy, P., et al., "Increased bone formation in osteocalcin-deficient mice," Nature (Aug. 1, 1996) 382:448-45